Research

Cystic fibrosis research: Improving therapy with CFTR modulators using short-chain fatty acids

Cystic fibrosis research: Improving therapy with CFTR modulators using short-chain fatty acids

The German Cystic Fibrosis Association (Bundesverband Mukoviszidose e.V.) is providing 148,330 euros to fund a project by Dr. Andrew Tony-Odigie’s working group (Heidelberg University Hospital) on the use of commensal (beneficial) bacteria and their metabolic products to improve therapy with CFTR modulators. The scientists are investigating previously unknown interactions between modulator therapy and commensals and […]

read more